TOKYO--(BUSINESS WIRE)--Alivexis, Inc. (headquartered in Tokyo, Japan, “Alivexis”) and Melodia Therapeutics AG (headquartered in Basel, Switzerland, “Melodia”), a company established by Forty51 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback